Advil Dual Action Coated Caplets for 8 Hour Pain Relief - 216 Count

Advil Dual Action Coated Caplets with Acetaminophen, the first and only FDA-approved pain relief medication, combine the top two selling pain-fighting ingredients for powerful results. Formulated with 250 mg ibuprofen to target pain at the source and 500 mg acetaminophen to block pain signals, these coated pain relief pills provide relief from a wide variety of aches and pains, including headache, toothache, menstrual cramp, muscle pain, and lower back pain, as well as minor aches and pains associated with arthritis. The combination of ibuprofen and acetaminophen in these Advil caplets allows users to take a lower maximum daily dose of each pain medication and still enjoy powerful, 8-hour relief (1).

Advil is a top-selling OTC pain reliever, providing safe and effective pain relief when used as directed for more than 35 years. By 2022, Advil will feature more sustainable packaging made with 20% less plastic per bottle, keeping nearly 500,000 pounds of plastic out of landfills.

The Advil Dual Action Coated Caplets with Acetaminophen provide multi-symptom pain relief, addressing a variety of aches and pains with a combination of ibuprofen and acetaminophen. The ibuprofen targets pain at the source, while the acetaminophen blocks pain signals, offering powerful relief with a lower maximum daily dose of each medication.

Advil's commitment to sustainability is also noteworthy, as the brand plans to introduce more eco-friendly packaging by 2022, reducing plastic usage and diverting nearly 500,000 pounds of plastic from landfills.

Overall, Advil Dual Action Coated Caplets with Acetaminophen offer a comprehensive pain relief solution, approved by the FDA and backed by Advil's trusted brand reputation for safe and effective pain management. The combination of ibuprofen and acetaminophen provides multi-symptom relief, while the upcoming sustainable packaging initiatives demonstrate Advil's commitment to environmental responsibility.

(1) 8 Hours of Relief - Searle S et al. Claim Substantiation. Clinical Study 2020 February.

product information: